Viking Therapeutics VKTX is preparing to release its quarterly earnings on Wednesday, 2025-07-23. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Viking Therapeutics to report an earnings per share (EPS) of $-0.44.
The announcement from Viking Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Overview of Past Earnings
Last quarter the company missed EPS by $0.10, which was followed by a 0.5% drop in the share price the next day.
Here's a look at Viking Therapeutics's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.27 | -0.25 | -0.27 |
| EPS Actual | -0.41 | -0.32 | -0.22 | -0.20 |
| Price Change % | -1.0% | -6.0% | 21.0% | 28.000000000000004% |
Market Performance of Viking Therapeutics's Stock
Shares of Viking Therapeutics were trading at $31.94 as of July 21. Over the last 52-week period, shares are down 37.15%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for Viking Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
